4.8 Article

Ubiquitin ligase Nedd4 promotes α-synuclein degradation by the endosomal-lysosomal pathway

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1109356108

Keywords

protein misfolding; neurodegeneration

Funding

  1. National Institute for Health Research, Oxford Biomedical Research Centre
  2. Harvard Medical School
  3. National Institute for Health Research (Academic Clinical Lectureship Scheme, Oxford)
  4. WellcomeTrust/Academy of Medical Sciences
  5. Parkinson's UK
  6. Hereditary Disease Foundation
  7. Converging Research Center
  8. Korean government
  9. M.J. Fox Foundation, National Institute of General Medical Sciences
  10. National Institute for Aging
  11. WCU
  12. Parkinson's UK [K-0819, J-0901] Funding Source: researchfish

Ask authors/readers for more resources

alpha-Synuclein is an abundant brain protein that binds to lipid membranes and is involved in the recycling of presynaptic vesicles. In Parkinson disease, alpha-synuclein accumulates in intraneuronal inclusions often containing ubiquitin chains. Here we show that the ubiquitin ligase Nedd4, which functions in the endosomal-lysosomal pathway, robustly ubiquitinates alpha-synuclein, unlike ligases previously implicated in its degradation. Purified Nedd4 recognizes the carboxyl terminus of alpha-synuclein (residues 120-133) and attaches K63-linked ubiquitin chains. In human cells, Nedd4 overexpression enhances alpha-synuclein ubiquitination and clearance by a lysosomal process requiring components of the endosomal-sorting complex required for transport. Conversely, Nedd4 down-regulation increases alpha-synuclein content. In yeast, disruption of the Nedd4 ortholog Rsp5p decreases alpha-synuclein degradation and enhances inclusion formation and alpha-synuclein toxicity. In human brains, Nedd4 is present in pigmented neurons and is expressed especially strongly in neurons containing Lewy bodies. Thus, ubiquitination by Nedd4 targets alpha-synuclein to the endosomal- lysosomal pathway and, by reducing alpha-synuclein content, may help protect against the pathogenesis of Parkinson disease and other alpha-synucleinopathies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available